Video

DDNA19: The role of the microbiome in liver disease

Publish date: April 4, 2019

 

REPORTING FROM DIGESTIVE DISEASES: NEW ADVANCES

Vidyard Video

Stephen Brant, MD, and Nikolaos Pyrsopoulos, MD, discuss the latest news and the role of the microbiome in liver diseases at Digestive Diseases: New Advances, jointly provided by Rutgers and Global Academy for Medical Education.

Global Academy and this news organization are owned by the same company.

Recommended Reading

Women survive more often than men do when hospitalized with cirrhosis
MDedge Internal Medicine
One-time, universal hepatitis C testing cost effective, researchers say
MDedge Internal Medicine
DDNA19: Cardiac Complications in Liver Disease Patients
MDedge Internal Medicine
Will inpatient albumin help in decompensated cirrhosis?
MDedge Internal Medicine
Cirrhosis model predicts decompensation across diverse populations
MDedge Internal Medicine
DDNA19: The NASH conundrum
MDedge Internal Medicine
For patients with end-stage liver disease, acute care incurs steep costs
MDedge Internal Medicine
For patients with HBV, daily aspirin may reduce risk of liver cancer
MDedge Internal Medicine
Novel microbiome signature may detect NAFLD-cirrhosis
MDedge Internal Medicine
Future of NASH care means multiple targets, multiple providers, expert says
MDedge Internal Medicine